The current CDXC market cap is 285.42M. The company's latest EPS is USD -0.0656 and P/E is -57.77.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 17.06M | 21M | 22.56M | 20.32M | 19.5M |
Operating Income | -3.07M | -1.44M | -1.97M | -2.32M | -1.15M |
Net Income | -985k | -1.42M | -1.9M | -2.19M | -959k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 46.29M | 59.26M | 67.45M | 72.05M | 83.57M |
Operating Income | -31.3M | -19.85M | -27.07M | -18.63M | -5.6M |
Net Income | -32.15M | -19.93M | -27.13M | -16.54M | -4.94M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 45.67M | 54.06M | 53.77M | 53.17M | 53.48M |
Total Liabilities | 24.64M | 25.39M | 25.75M | 26.02M | 26.18M |
Total Equity | 21.02M | 28.67M | 28.02M | 27.15M | 27.31M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 40.25M | 38.36M | 57.84M | 54.06M | 54.96M |
Total Liabilities | 19.8M | 21.93M | 26.11M | 25.39M | 26.51M |
Total Equity | 20.45M | 16.42M | 31.73M | 28.67M | 28.46M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.77M | -15.1M | 2.79M | 6.07M | 6.47M |
Investing | -162k | -334k | -91k | -96k | -122k |
Financing | -25k | 7.65M | -1,000 | -11k | -14k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -20.44M | -10.6M | -24.16M | -15.1M | 7.12M |
Investing | -249k | -165k | -409k | -334k | -143k |
Financing | 16.88M | 8.65M | 36.09M | 7.65M | -90k |
Market Cap | 285.42M |
Price to Earnings Ratio | -57.77 |
Price to Sales Ratio | 3.42 |
Price to Cash Ratio | 10.5 |
Price to Book Ratio | 10.03 |
Dividend Yield | - |
Shares Outstanding | 75.31M |
Average Volume (1 week) | 297.66k |
Average Volume (1 Month) | 461.89k |
52 Week Change | 166.90% |
52 Week High | 4.65 |
52 Week Low | 1.25 |
Spread (Intraday) | 0.21 (5.28%) |
Company Name | ChromaDex Corporation |
Address |
838 walker road dover, delaware 19904 |
Website | https://www.chromadex.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.